Stocks and Investing Stocks and Investing
Tue, November 7, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Atkin Maintained (AMT) at Buy with Increased Target to $204 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Noah Kaye Downgraded (AMRC) to Hold on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Tim Mulrooney Downgraded (AMRC) to Hold on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Maintained (AMRC) at Buy with Decreased Target to $40 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
David Saxon Maintained (ATEC) at Strong Buy with Decreased Target to $16 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Mathew Blackman Maintained (ATEC) at Strong Buy with Decreased Target to $24 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
James Friedman Maintained (AVDX) at Buy with Decreased Target to $11 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (AWK) at Strong Buy with Increased Target to $140 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Charles Duncan Reiterated (AXSM) at Buy and Held Target at $108 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Clarke Jeffries Reiterated (AZPN) at Hold and Held Target at $180 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
David Lebowitz Initiated (BBIO) at Strong Buy and Held Target at $42 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AES) at Buy with Increased Target to $18 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Mcveigh Initiated (ADP) at Hold and Held Target at $235 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Mike Genovese Downgraded (ADTN) to Hold and Decreased Target to $7 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Chris Pierce Reiterated (ACVA) at Strong Buy and Held Target at $23 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Alex Scott Maintained (ALL) at Strong Buy with Increased Target to $141 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Joel Jackson Maintained (ALB) at Buy with Decreased Target to $180 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Mcveigh Initiated (ALIT) at Strong Buy and Held Target at $10 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (ALGT) at Hold with Decreased Target to $95 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Benjamin Swinburne Maintained (WBD) at Hold with Decreased Target to $14 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Harrigan Maintained (WBD) at Strong Buy with Decreased Target to $24 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Ken Herbert Maintained (VVX) at Buy with Decreased Target to $55 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Brian Gesuale Maintained (VVX) at Strong Buy with Decreased Target to $60 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (WERN) at Buy with Decreased Target to $61 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Lloyd Walmsley Maintained (BKNG) at Strong Buy on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Michael Binetti Initiated (birk) at Buy and Held Target at $47 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Luca Issi Reiterated (BMRN) at Hold and Held Target at $100 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Strelzik Maintained (BLMN) at Hold with Decreased Target to $24 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Bruce Jackson Reiterated (BLTE) at Strong Buy and Held Target at $57 on, Nov 7th, 2023
[ 12:00 AM ] - WOPRAI
Emily Bodnar Downgraded (VTYX) to Hold on, Nov 7th, 2023

Emily Bodnar Downgraded (VTYX) to Hold on, Nov 7th, 2023


Published on 2024-10-28 07:23:07 - WOPRAI, Emily Bodnar
  Print publication without navigation


Emily Bodnar of HC Wainwright & Co., Downgraded "Ventyx Biosciences, Inc." (VTYX) to Hold on, Nov 7th, 2023.

Emily has made no other calls on VTYX in the last 4 months.



There are 2 other peers that have a rating on VTYX. Out of the 2 peers that are also analyzing VTYX, 0 agree with Emily's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Emily

  • Simon Flannery of "Morgan Stanley" Maintained at Buy with Increased Target to $46 on, Tuesday, August 29th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $62 on, Friday, August 11th, 2023
Contributing Sources